SpeedWeed

AUGUST 16, 2021

Lepp was one of the industry’s greatest advocates, leaving his mark as one of many who suffered in prison as a result of trying to cultivate medical cannabis and help patients get access. Lepp received a 10-year prison sentence in September 2009 at age 56. Sadly, the defense wasn’t enough. The presiding U.S.

DEA 52

DEA Patients Therapy Cannabis 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D., Members of the U.S.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Meadow

JULY 13, 2018

we want everyone who did not have the opportunity to attend Meadowlands to have access to this content. I moved to San Francisco in 2006 and started my time in city government in 2009, so I spent over a decade in city hall working for two administrations. So please feel free to share this post with your network and your community?—?we

Wellness and Beauty 40

Wellness and Beauty Consumption Policy Cannabis 40

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. Sessions wrote. “In 2 1 U.S.C. § 801 et seq. It has established significant penalties for these crimes. 2 1 U.S.C. §

Banking 45

Banking Law Marijuana State Laws 45